Welcome to Genomics Now, a podcast series where you can learn how genomics is developing in England's NHS. This podcast series is recorded in 2024 and is part of the North Thames Genomic Medicine Services Educational Toolkit. In each bite-sized episode, we explore what is changing in genomics. We answer the questions on genomics we've been asked by different healthcare professionals, discuss how genomics may impact various healthcare roles, and examine how genomics can be used to successfully improve patient care.

In today’s episode, we delve into the clinician's perspective on NHS England's liquid biopsy circulating tumour DNA pilot. Hosted by Dr. Shazia Mahamdallie, this episode features Dr. Alistair Greystoke, a Professor of Oncology, and Dr. William Ricketts, a Consultant chest physician. They discuss the integration and impact of liquid biopsy testing on lung cancer diagnosis and patient care.

Join us and learn about the practical tips, patient benefits, and logistical challenges encountered during the pilot, as well as the promising future applications of liquid biopsy testing in diagnostics and treatment monitoring. Tune in for an engaging and informative discussion that highlights the potential of genomics to change how we deliver healthcare.

For more resources and updates on genomic-based clinical developments and research, visit the North Thames Genomic Medicine Service website. If you enjoyed this episode, share your thoughts and spread the word on social media by tagging the North Thames Genomic Medicine Service.